pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ELI LILLY CO · news · pharmadog
← back to ELI LILLY CO
News mentioning ELI LILLY CO
630
stories
Sep 24, 26
FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with Novo
endpoints
Sep 24, 26
Lilly’s latest China drug deal; Immunovant’s setback in lupus
biopharma dive
Sep 24, 26
STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more
stat
Sep 24, 26
Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry
biospace
Sep 24, 26
Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare
biospace
Sep 24, 26
In another China pact, Lilly makes a deal with InnoCare worth up to $3.35B
endpoints
Sep 24, 26
Growth mode: 3 biotechs that are staffing up after series B raises
biospace
Sep 24, 26
Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare
fiercebiotech
Sep 23, 26
‘It’s certainly not easy’: How are Boston biotechs coping with a shallower pool of seed funding?
fiercebiotech
Sep 23, 26
The latest in the legal saga for youth gender-affirming care in the U.S.
stat
Sep 23, 26
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
biospace
Sep 23, 26
STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments
stat
Sep 23, 26
9 companies hiring in Pennsylvania now
biospace
Sep 23, 26
Pharmas face off for manufacturing talent amidst reshoring efforts
biospace
Sep 22, 26
STAT+: Did the Trump administration just cut Novo a huge financial win?
stat
Sep 22, 26
Viking shares surge on updated obesity drug data
biopharma dive
Sep 22, 26
Viking achieves 'maintenance trifecta' as GLP-1/GIP dual agonist exceeds expectations
biospace
Sep 22, 26
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
biospace
Sep 22, 26
Lilly presents early data supporting GLP-1/GIP candidate's potential in depression, alcohol use disorder
biospace
Sep 22, 26
STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
stat
Sep 22, 26
2026 IPO blitz continues with 4 new biotech filings
biospace
Sep 22, 26
An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slide
biopharma dive
Sep 22, 26
Novo’s workforce reduction climbs to 13,000 to fuel R&D work
biospace
Sep 22, 26
Roche’s Carmot asset normalizes blood sugar, cuts weight in Phase 2 diabetes trial
biospace
Sep 22, 26
Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
fiercebiotech
Sep 21, 26
Novo talks up drug launches in effort to win back investors
biopharma dive
Sep 21, 26
Pfizer, Lilly 'most favored nation' deals to give US share of raised foreign prices
endpoints
Sep 21, 26
Novo offers low-dose CagriSema data as approval decision looms
endpoints
Sep 21, 26
STAT+: Lilly’s breast cancer combo wins approval
stat
Sep 21, 26
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting
biospace
← prev
page 6 of 21
next →
